Cargando…

Significance of System L Amino Acid Transporter 1 (LAT-1) and 4F2 Heavy Chain (4F2hc) Expression in Human Developing Intestines

To clarify the significance of expression of system L amino acid transporter 1 (LAT1) and 4F2 heavy chain (4F2hc) in the developing intestine, immunohistochemical investigation and molecular analysis were performed in the human embryonic and/or fetal intestines, ranging from 28–30 days to 34–35 week...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ohno, Chikara, Nakanishi, Yohko, Honma, Taku, Henmi, Akihiro, Sugitani, Masahiko, Kanai, Yoshikatsu, Nemoto, Norimichi
Formato:	Texto
Lenguaje:	English
Publicado:	Japan Society of Histochemistry and Cytochemistry 2009
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2711394/ https://www.ncbi.nlm.nih.gov/pubmed/19617954 http://dx.doi.org/10.1267/ahc09010

Ejemplares similares

Establishment of Stable Cell Lines With High Expression of Heterodimers of Human 4F2hc and Human Amino Acid Transporter LAT1 or LAT2 and Delineation of Their Differential Interaction With α-Alkyl Moieties
por: Khunweeraphong, Narakorn, et al.
Publicado: (2012)

The Heavy Chain 4F2hc Modulates the Substrate Affinity and Specificity of the Light Chains LAT1 and LAT2
por: Kantipudi, Satish, et al.
Publicado: (2020)

Yeast Cell-Based Transport Assay for the Functional Characterization of Human 4F2hc-LAT1 and ‐LAT2, and LAT1 and LAT2 Substrates and Inhibitors
por: Kantipudi, Satish, et al.
Publicado: (2021)

Relation of LAT1/4F2hc expression with pathological grade, proliferation and angiogenesis in human gliomas
por: Haining, Zhen, et al.
Publicado: (2012)

Mechanism of substrate transport and inhibition of the human LAT1-4F2hc amino acid transporter
por: Yan, Renhong, et al.
Publicado: (2021)

LAPTM4b recruits the LAT1-4F2hc Leu transporter to lysosomes and promotes mTORC1 activation
por: Milkereit, Ruth, et al.
Publicado: (2015)

Structural insight into the substrate recognition and transport mechanism of the human LAT2–4F2hc complex
por: Yan, Renhong, et al.
Publicado: (2020)

Contribution of LAT1-4F2hc in Urological Cancers via Toll-like Receptor and Other Vital Pathways
por: Zhao, Xue, et al.
Publicado: (2022)

Negative regulation of amino acid signaling by MAPK-regulated 4F2hc/Girdin complex
por: Weng, Liang, et al.
Publicado: (2018)

Volta Phase Plate Cryo-EM Structure of the Human Heterodimeric Amino Acid Transporter 4F2hc-LAT2
por: Jeckelmann, Jean-Marc, et al.
Publicado: (2019)

Sub-Nanometer Cryo-EM Density Map of the Human Heterodimeric Amino Acid Transporter 4F2hc-LAT2
por: Jeckelmann, Jean-Marc, et al.
Publicado: (2020)

Pichia pastoris and the Recombinant Human Heterodimeric Amino Acid Transporter 4F2hc-LAT1: From Clone Selection to Pure Protein
por: Kantipudi, Satish, et al.
Publicado: (2021)

Detergent-Induced Stabilization and Improved 3D Map of the Human Heteromeric Amino Acid Transporter 4F2hc-LAT2
por: Meury, Marcel, et al.
Publicado: (2014)

Methylmercury Uptake into BeWo Cells Depends on LAT2-4F2hc, a System L Amino Acid Transporter
por: Balthasar, Christina, et al.
Publicado: (2017)

Characterization of substrates and inhibitors of the human heterodimeric transporter 4F2hc-LAT1 using purified protein and the scintillation proximity radioligand binding assay
por: Kantipudi, Satish, et al.
Publicado: (2023)

Structure of the human heterodimeric transporter 4F2hc-LAT2 in complex with Anticalin, an alternative binding protein for applications in single-particle cryo-EM
por: Jeckelmann, Jean-Marc, et al.
Publicado: (2022)

Expression of Somatostatin Receptor (SSTR) Subtypes (SSTR-1, 2A, 3, 4 and 5) in Neuroendocrine Tumors Using Real-time RT-PCR Method and Immunohistochemistry
por: Mizutani, Gou, et al.
Publicado: (2012)

Inhibition of cancer-type amino acid transporter LAT1 suppresses B16-F10 melanoma metastasis in mouse models
por: Shi, Zitong, et al.
Publicado: (2023)

Dependence of proliferative vascular smooth muscle cells on CD98hc (4F2hc, SLC3A2)
por: Fogelstrand, Per, et al.
Publicado: (2009)

The Ectodomains of rBAT and 4F2hc Are Fake or Orphan α-Glucosidases
por: Fort, Joana, et al.
Publicado: (2021)

Boronophenylalanine, a boron delivery agent for boron neutron capture therapy, is transported by ATB(0,+), LAT1 and LAT2
por: Wongthai, Printip, et al.
Publicado: (2015)

Lat(Y136F) knock-in mouse model for human IgG4-related disease
por: Yamada, Kazunori, et al.
Publicado: (2018)

Proteomics and phosphoproteomics reveal key regulators associated with cytostatic effect of amino acid transporter LAT1 inhibitor
por: Okanishi, Hiroki, et al.
Publicado: (2020)

Pharmacologic inhibition of LAT1 predominantly suppresses transport of large neutral amino acids and downregulates global translation in cancer cells
por: Nishikubo, Kou, et al.
Publicado: (2022)

The pronounced lung lesions developing in LAT(Y136F) knock-in mice mimic human IgG4-related lung disease
por: Waseda, Yuko, et al.
Publicado: (2021)

The structure of erastin-bound xCT–4F2hc complex reveals molecular mechanisms underlying erastin-induced ferroptosis
por: Yan, Renhong, et al.
Publicado: (2022)

Expression of L-type amino acid transporter 1 (LAT1) as a prognostic and therapeutic indicator in multiple myeloma
por: Isoda, Atsushi, et al.
Publicado: (2014)

α‐Emitting cancer therapy using (211)At‐AAMT targeting LAT1
por: Kaneda‐Nakashima, Kazuko, et al.
Publicado: (2021)

Combination effects of amino acid transporter LAT1 inhibitor nanvuranlat and cytotoxic anticancer drug gemcitabine on pancreatic and biliary tract cancer cells
por: Nishikubo, Kou, et al.
Publicado: (2023)

Targeting N-glycosylation of 4F2hc mediated by glycosyltransferase B3GNT3 sensitizes ferroptosis of pancreatic ductal adenocarcinoma
por: Ma, Heng, et al.
Publicado: (2023)

LAT1 (SLC7A5) and CD98hc (SLC3A2) complex dynamics revealed by single-particle cryo-EM
por: Chiduza, George N., et al.
Publicado: (2019)

[18F] FDOPA standardized uptake values of brain tumors are not exclusively dependent on LAT1 expression
por: Dadone-Montaudié, Bérengère, et al.
Publicado: (2017)

L-type amino acid transporter (LAT) 1 expression in (18)F-FET-negative gliomas
por: Vettermann, Franziska J., et al.
Publicado: (2021)

Expressions of Somatostatin Receptor Subtypes (SSTR-1, 2, 3, 4 and 5) in Neuroblastic Tumors; Special Reference to Clinicopathological Correlations with International Neuroblastoma Pathology Classification and Outcomes
por: Watanabe, Noriko, et al.
Publicado: (2014)

Specific transport of 3‐fluoro‐l‐α‐methyl‐tyrosine by LAT1 explains its specificity to malignant tumors in imaging
por: Wei, Ling, et al.
Publicado: (2016)

Evaluation of LATS1 and LATS2 Promoter Methylation with the Risk of Pterygium Formation
por: Najafi, Maryam, et al.
Publicado: (2016)

Amino acid transporter LAT1 in tumor-associated vascular endothelium promotes angiogenesis by regulating cell proliferation and VEGF-A-dependent mTORC1 activation
por: Quan, Lili, et al.
Publicado: (2020)

(18)F-FIMP: a LAT1-specific PET probe for discrimination between tumor tissue and inflammation
por: Nozaki, Satoshi, et al.
Publicado: (2019)

The heavy chain of 4F2 antigen promote prostate cancer progression via SKP-2
por: Maimaiti, Maihulan, et al.
Publicado: (2021)

LATS1 but not LATS2 represses autophagy by a kinase-independent scaffold function
por: Tang, Fengyuan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_fsni9p7s8tprqe3glevtog4op7